Np Life Sciences Health Industry Group Inc (NPLS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NPLS Annual Balance Sheets →
Balance sheet data covering Np Life Sciences Health Industry Group Inc–Dec 31 2022 offers a view into how Dec 31 2023's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2023)
(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent0.07
Cash & Short-term Investments0.00
Prepaid Expense, Current AS0.01
Total Current Assets0.00
Other Assets, Noncurrent0.00
Total Assets0.08
Liabilities
Accounts Payable, Current AC0.01
Accrued Liabilities, Current AC0.03
Other Notes Payable, Current OT0.01
Taxes Payable, Current, Total0.00
Total Current Liabilities0.04
Total Long-term Debt0.00
Other liabilities, Noncurrent0.02
Contract With Customer Liability Current-
Total Liabilities0.06
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock0.36
Retained Earnings / Accumulated Deficit-0.35
Other Equity0.00
Common Stockholder's Equity0.02
Total Stockholder's Equity0.02
Liabilities & Stockholder's Equity0.08
4 historic quarters locked

Sign in to unlock the full Np Life Sciences Health Industry Group Inc balance sheet history.

About Np Life Sciences Health Industry Group Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: April 16, 2024
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-24-014774

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.